Skip to main content

Rhenman & Partners Asset Management AB

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1599882 Stockholm, V7

Position in MIRM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$16,296,729
+$7,741,880 QoQ
Shares Held
139,205
+50.3% QoQ
Ownership
0.214%
of shares outstanding
% of Portfolio
1.54%
of 13F equity value
Holder Rank
#75
of 327 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MIRM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $335,352,902 across 39 Biotechnology names. MIRM ranks #5 (4.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 MIRM
Mirum Pharmaceuticals, Inc.
This page
139,205 $16,296,729

All Filings in MIRM

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,296,729 139,205
2026-03-31 $8,554,849 92,605
2025-12-31 $8,393,082 106,255
2025-09-30 $4,124,054 56,255
2025-06-30 $3,346,271 65,755
2025-03-31 $3,322,662 73,755
2024-12-31 $3,049,769 73,755
2024-09-30 $4,095,000 105,000
2024-06-30 $4,590,007 134,250
2024-03-31 $2,317,320 92,250